Physician profile
Roberto Flores
NPI 1528222890
$30,245.85
in general payments reported to CMS, 2019-2025
8 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $6,655 · 2023: $7,417 · 2024: $16K · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $7,135 · Honoraria: $2,500 · Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,500.00 |
| Travel and Lodging | $7,135.40 |
| Honoraria | $2,500.00 |
| Food and Beverage | $1,455.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $22,678.63 | 2022-2025 | |
| Medical Device Business Services, INC. | $6,660.78 | 2022-2023 | |
| Stryker Corporation | $300.71 | 2023-2024 | Vsp System, Vsp Cranial, Delta, Na |
| Integra Lifesciences Corporation | $252.27 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $152.63 | 2022-2023 | Trumatch |
| Sientra, INC. | $136.05 | 2022 | |
| Kerecis Limited | $43.55 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Zimmer Biomet Holdings, INC. | $21.23 | 2025 | Tru-Link Suture |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.